Livforsakringsbolaget Skandia Omsesidigt lowered its position in Clorox Co (NYSE:CLX) by 55.9% during the first quarter, Holdings Channel reports. The institutional investor owned 1,151 shares of the company’s stock after selling 1,460 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Clorox were worth $185,000 as of its most recent SEC filing.
Several other institutional investors have also recently modified their holdings of CLX. Athena Capital Advisors LLC purchased a new stake in Clorox during the 4th quarter worth approximately $25,000. Meeder Asset Management Inc. purchased a new stake in Clorox during the 4th quarter worth approximately $26,000. Capital Financial Planning LLC purchased a new stake in Clorox during the 4th quarter worth approximately $32,000. Paragon Capital Management LLC purchased a new stake in Clorox during the 1st quarter worth approximately $35,000. Finally, Penserra Capital Management LLC purchased a new stake in Clorox during the 1st quarter worth approximately $36,000. 77.92% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Clorox stock traded down $1.25 during trading hours on Friday, reaching $149.63. 728,733 shares of the company’s stock were exchanged, compared to its average volume of 1,042,215. Clorox Co has a 1 year low of $119.78 and a 1 year high of $167.70. The firm has a market capitalization of $19.06 billion, a price-to-earnings ratio of 23.90, a PEG ratio of 4.31 and a beta of 0.31. The company has a quick ratio of 0.66, a current ratio of 1.10 and a debt-to-equity ratio of 2.93.
Clorox (NYSE:CLX) last released its earnings results on Wednesday, May 1st. The company reported $1.44 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.47 by ($0.03). Clorox had a return on equity of 108.82% and a net margin of 12.68%. The business had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.57 billion. During the same period in the previous year, the company earned $1.37 EPS. Clorox’s quarterly revenue was up 2.2% compared to the same quarter last year. On average, research analysts anticipate that Clorox Co will post 6.29 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 16th. Stockholders of record on Wednesday, July 31st will be issued a dividend of $1.06 per share. This is a positive change from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date is Tuesday, July 30th. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.83%. Clorox’s dividend payout ratio is presently 61.34%.
In other news, SVP Andrew J. Mowery sold 5,340 shares of the company’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $156.44, for a total transaction of $835,389.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.40% of the stock is owned by corporate insiders.
Several analysts have weighed in on CLX shares. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $177.00 target price on the stock in a research report on Monday, March 11th. BMO Capital Markets set a $175.00 price objective on shares of Clorox and gave the company a “buy” rating in a research note on Tuesday, February 5th. Wells Fargo & Co restated a “hold” rating and set a $157.00 price objective on shares of Clorox in a research note on Thursday, February 21st. Credit Suisse Group began coverage on shares of Clorox in a research note on Wednesday, March 6th. They set an “outperform” rating and a $172.00 price objective for the company. Finally, Barclays restated a “hold” rating and set a $142.00 price objective on shares of Clorox in a research note on Wednesday, February 6th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. Clorox currently has an average rating of “Hold” and a consensus target price of $149.29.
TRADEMARK VIOLATION NOTICE: “Livforsakringsbolaget Skandia Omsesidigt Has $185,000 Stake in Clorox Co (CLX)” was first posted by Stock Observer and is the property of of Stock Observer. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this news story can be viewed at https://www.thestockobserver.com/2019/05/25/livforsakringsbolaget-skandia-omsesidigt-has-185000-stake-in-clorox-co-clx.html.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Further Reading: Differences Between Momentum Investing and Long Term Investing
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.